{"listing":{"listing_type":"company","name":"Xylo bio","slug":"xylo-bio","tagline":"Transforming Lives with Targeted Neurotherapeutics","description":"Transforming Lives with Targeted Neurotherapeutics\n\nXylo bio is a Startmate portfolio company (cohort W21).","url":"https://www.xylo.bio/","is_stealth":false,"normalized_domain":"xylo.bio","normalized_url_key":"xylo.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://cdn.prod.website-files.com/67a04d9737a8868afb7c66b5/689157485cf5480888c97af7_xylo%20bio%20logo.webp","links":[{"label":"Startmate portfolio profile","url":"https://www.startmate.com/portfolio-companies/xylo-bio","platform":"startmate"}],"entry_points":[{"kind":"homepage","url":"https://www.xylo.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.xylo.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Mental Health","Startmate"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/xylobio/","contact_email":null,"added_at":"2026-09-04T12:53:04.383Z","added_via":"web","geo":{"keywords":["Startmate","Mental Health"],"canonical_facts":["Startmate portfolio company","Startmate cohort: W21","Valuation band per Startmate: $10-50m"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-04T12:53:04.383Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"mental-health","name":"Mental Health","note":null,"profile_url":"/industries/mental-health"},{"kind":"industry","slug":"startmate","name":"Startmate","note":null,"profile_url":"/industries/startmate"}]}}